Blog

Blog2018-05-01T17:49:07+00:00
28Aug 2017

DIABETES PIPELINE ANALYSIS – MERCK

August 28th, 2017|Categories: Business, Data Analytics, Diabetes|0 Comments

Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in Sales in 2016.3 Januvia® is especially known for its great cardiovascular safety profile, which has helped differentiate itself in its class. But Merck has no plans of stopping there with four different products [...]

4Aug 2017

WHAT DO THE BIG PLAYERS HAVE IN STORE FOR THE DIABETES MARKET IN THE NEXT 12 MONTHS?

August 4th, 2017|Categories: Chronic Disease, Diabetes|0 Comments

Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients, according to the CDC1 and represents over a $50 billion dollar industry2. Pharmaceutical companies are constantly racing to create the next market leader, and 2018 will be [...]

2Aug 2017

Letting the Data Tell the Story

August 2nd, 2017|Categories: Business, Data Analytics|Tags: , , |0 Comments

In our previous post we described the technique for assigning categories to data, based on input from content experts within a “training database”.  This technique is effective for summarizing large, text-heavy data into specific categories for summaries and improved visualization.  While this approach is useful for those purposes, it will [...]

24Jul 2017

USING NLP TECHNIQUES TO CLASSIFY PATIENT SEGMENTS IN CLINICAL TRIAL DATA

July 24th, 2017|Categories: Business, Data Analytics|Tags: , , |0 Comments

One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for a portion of the dataset and then analyze these labels to apply to the rest of the dataset. Some key questions need to be answered when applying this [...]

14Jul 2017

Finding the Needle in the Haystack with NLP

July 14th, 2017|Categories: Business, Data Analytics|Tags: , , |0 Comments

The problem with Big Data is that it is so Big!  This issue is especially true in the world of healthcare and drug development.  It is difficult to see across all the good clinical/scientific work going on around the world and understand exactly where we are headed and how we [...]

12Jul 2017

We’re Back!

July 12th, 2017|Categories: Business|0 Comments

Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have compiled the world’s largest free comprehensive global clinical trial database, as well as an intuitive tool that enables effective and efficient analytic management. The free data base will be available [...]